{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:59:26Z","timestamp":1781171966156,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04133-4","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:19:23Z","timestamp":1781169563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of corneal morphology, pupillometry, and ocular surface parameters in Fabry disease patients: correlation with plasma Lyso-Gb3 levels"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0748-6416","authenticated-orcid":false,"given":"Ali","family":"Dal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fcnyamin","family":"Kutluksaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talip","family":"Akikol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Erda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Canleblebici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk Hilmi","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"4133_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/J.1365-2362.2004.01309.X","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U et al (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Invest 34:236\u2013242. https:\/\/doi.org\/10.1111\/J.1365-2362.2004.01309.X","journal-title":"Eur J Clin Invest"},{"key":"4133_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/S13023-025-03922-X","volume":"20","author":"RJ Hopkin","year":"2025","unstructured":"Hopkin RJ, Laney D, Kazemi S et al (2025) Fabry disease in females: organ involvement and clinical outcomes compared with the general population. Orphanet J Rare Dis 20:433. https:\/\/doi.org\/10.1186\/S13023-025-03922-X","journal-title":"Orphanet J Rare Dis"},{"key":"4133_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/GENES15010037","author":"R Izhar","year":"2023","unstructured":"Izhar R, Borriello M, La Russa A et al (2023) Fabry disease in women: genetic basis, available biomarkers, and clinical manifestations. Genes Basel. https:\/\/doi.org\/10.3390\/GENES15010037","journal-title":"Genes Basel"},{"key":"4133_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02392-9","author":"M Beck","year":"2022","unstructured":"Beck M, Ramaswami U, Hernberg-St\u00e5hl E et al (2022) Twenty years of the Fabry outcome survey (FOS): insights, achievements, and lessons learned from a global patient registry. Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/s13023-022-02392-9","journal-title":"Orphanet J Rare Dis"},{"key":"4133_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-018-30688-Z","author":"G Bitirgen","year":"2018","unstructured":"Bitirgen G, Turkmen K, Malik RA et al (2018) Corneal confocal microscopy detects corneal nerve damage and increased dendritic cells in Fabry disease. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-018-30688-Z","journal-title":"Sci Rep"},{"key":"4133_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2019.129437","author":"JJ Miller","year":"2020","unstructured":"Miller JJ, Kanack AJ, Dahms NM (2020) Progress in the understanding and treatment of Fabry disease. Biochimica et Biophysica Acta (BBA)\u2014Gen Subjects. https:\/\/doi.org\/10.1016\/j.bbagen.2019.129437","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Gen Subjects"},{"key":"4133_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435. https:\/\/doi.org\/10.1016\/S0140-6736(08)61589-5","journal-title":"Lancet"},{"key":"4133_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/MUS.21606","volume":"41","author":"R Liguori","year":"2010","unstructured":"Liguori R, Di Stasi V, Bugiardini E et al (2010) Small fiber neuropathy in female patients with Fabry disease. Muscle Nerve 41:409\u2013412. https:\/\/doi.org\/10.1002\/MUS.21606","journal-title":"Muscle Nerve"},{"key":"4133_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-38","author":"M Biegstraaten","year":"2010","unstructured":"Biegstraaten M, van Schaik IN, Wieling W et al (2010) Autonomic neuropathy in Fabry disease: a prospective study using the autonomic symptom profile and cardiovascular autonomic function tests. BMC Neurol. https:\/\/doi.org\/10.1186\/1471-2377-10-38","journal-title":"BMC Neurol"},{"key":"4133_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ANA.410310410","volume":"31","author":"GA de Veber","year":"1992","unstructured":"de Veber GA, Schwarting GA, Kolodny EH et al (1992) Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 31:409\u2013415. https:\/\/doi.org\/10.1002\/ANA.410310410","journal-title":"Ann Neurol"},{"key":"4133_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ANA.410230513","volume":"23","author":"EM Kaye","year":"1988","unstructured":"Kaye EM, Kolodny EH, Logigian EL et al (1988) Nervous system involvement in Fabry\u2019s disease: clinicopathological and biochemical correlation. Ann Neurol 23:505\u2013509. https:\/\/doi.org\/10.1002\/ANA.410230513","journal-title":"Ann Neurol"},{"key":"4133_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0190-9622(87)70274-6","volume":"17","author":"S Lee","year":"1987","unstructured":"Lee S, Chun SI (1987) Generalized anhidrosis associated with Fabry\u2019s disease. J Am Acad Dermatol 17:883\u2013887. https:\/\/doi.org\/10.1016\/S0190-9622(87)70274-6","journal-title":"J Am Acad Dermatol"},{"key":"4133_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0923-1811(98)00032-2","volume":"18","author":"LM Lao","year":"1998","unstructured":"Lao LM, Kumakiri M, Mima H et al (1998) The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci 18:109\u2013117. https:\/\/doi.org\/10.1016\/S0923-1811(98)00032-2","journal-title":"J Dermatol Sci"},{"key":"4133_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010061","author":"A Tuttolomondo","year":"2023","unstructured":"Tuttolomondo A, Baglio I, Riolo R et al (2023) Molecular pathogenesis of central and peripheral nervous system complications in anderson-Fabry disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010061","journal-title":"Int J Mol Sci"},{"key":"4133_CR15","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1097\/HJH.0B013E32834C31DB","volume":"29","author":"MJ Hilz","year":"2011","unstructured":"Hilz MJ, Koehn J, Kolodny EH et al (2011) Metronomic breathing shows altered parasympathetic baroreflex function in untreated Fabry patients and baroreflex improvement after enzyme replacement therapy. J Hypertens 29:2387\u20132394. https:\/\/doi.org\/10.1097\/HJH.0B013E32834C31DB","journal-title":"J Hypertens"},{"key":"4133_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-021-97599-4","author":"S You","year":"2021","unstructured":"You S, Hong JH, Yoo J (2021) Analysis of pupillometer results according to disease stage in patients with Parkinson\u2019s disease. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-021-97599-4","journal-title":"Sci Rep"},{"key":"4133_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/J.JTOS.2017.05.009","volume":"15","author":"GD Novack","year":"2017","unstructured":"Novack GD, Asbell P, Barabino S et al (2017) TFOS DEWS II clinical trial design report. Ocul Surf 15:629. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.009","journal-title":"Ocul Surf"},{"key":"4133_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/J.PRETEYERES.2009.04.003","volume":"28","author":"DA Dartt","year":"2009","unstructured":"Dartt DA (2009) Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res 28:155. https:\/\/doi.org\/10.1016\/J.PRETEYERES.2009.04.003","journal-title":"Prog Retin Eye Res"},{"key":"4133_CR19","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1007\/S10072-025-08182-Y","volume":"46","author":"D \u0130\u015fcan","year":"2025","unstructured":"\u0130\u015fcan D, T\u00fcrko\u011flu C, Arslan E (2025) Evaluation of autonomic involvement in Parkinson\u2019s disease using pupillometry. Neurol Sci 46:3685\u20133690. https:\/\/doi.org\/10.1007\/S10072-025-08182-Y","journal-title":"Neurol Sci"},{"key":"4133_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/ARCHOPHT.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615\u2013621. https:\/\/doi.org\/10.1001\/ARCHOPHT.118.5.615","journal-title":"Arch Ophthalmol"},{"key":"4133_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09273940701486803","volume":"15","author":"F \u00d6zcura","year":"2007","unstructured":"\u00d6zcura F, Aydin S, Helvaci MR (2007) Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 15:389\u2013393. https:\/\/doi.org\/10.1080\/09273940701486803","journal-title":"Ocul Immunol Inflamm"},{"key":"4133_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/J.OPHTHA.2007.06.031","volume":"115","author":"R Arita","year":"2008","unstructured":"Arita R, Itoh K, Inoue K et al (2008) Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmol 115:911\u2013915. https:\/\/doi.org\/10.1016\/J.OPHTHA.2007.06.031","journal-title":"Ophthalmol"},{"key":"4133_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cegh.2020.01.010","volume":"8","author":"AV Siva kumar","year":"2020","unstructured":"Siva kumar AV, Maruthy KN, Padmavathi R et al (2020) Quantitative determination of pupil by dynamic pupillometry using infrared videography\u2014role in evaluation of autonomic activity. Clin Epidemiol Glob Health 8:728\u2013732. https:\/\/doi.org\/10.1016\/j.cegh.2020.01.010","journal-title":"Clin Epidemiol Glob Health"},{"key":"4133_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0168-8227(94)90140-6","volume":"26","author":"SJ Piha","year":"1994","unstructured":"Piha SJ, Halonen JP (1994) Infrared pupillometry in the assessment of autonomic function. Diabetes Res Clin Pract 26:61\u201366. https:\/\/doi.org\/10.1016\/0168-8227(94)90140-6","journal-title":"Diabetes Res Clin Pract"},{"key":"4133_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/FNEUR.2019.00129","volume":"10","author":"C Kelbsch","year":"2019","unstructured":"Kelbsch C, Strasser T, Chen Y et al (2019) Standards in pupillography. Front Neurol 10:129. https:\/\/doi.org\/10.3389\/FNEUR.2019.00129","journal-title":"Front Neurol"},{"key":"4133_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clae.2011.07.005","volume":"35","author":"H Pult","year":"2012","unstructured":"Pult H, Riede-Pult BH (2012) A new modified fluorescein strip: its repeatability and usefulness in tear film break-up time analysis. Cont Lens Anterior Eye 35:35\u201338. https:\/\/doi.org\/10.1016\/j.clae.2011.07.005","journal-title":"Cont Lens Anterior Eye"},{"key":"4133_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/S40360-017-0152-7","author":"K Tsuboi","year":"2017","unstructured":"Tsuboi K, Yamamoto H (2017) Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-na\u00efve Fabry disease patients. BMC Pharmacol Toxicol. https:\/\/doi.org\/10.1186\/S40360-017-0152-7","journal-title":"BMC Pharmacol Toxicol"},{"key":"4133_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11020271","volume":"11","author":"K Kok","year":"2021","unstructured":"Kok K, Zwiers KC, Boot RG et al (2021) Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions. Biomolecules 11:1\u201320. https:\/\/doi.org\/10.3390\/biom11020271","journal-title":"Biomolecules"},{"key":"4133_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5315137","author":"Y Ikegawa","year":"2018","unstructured":"Ikegawa Y, Shiraishi A, Hayashi Y et al (2018) In Vivo confocal microscopic observations of vortex keratopathy in patients with amiodarone-induced keratopathy and fabry disease. J Ophthalmol. https:\/\/doi.org\/10.1155\/2018\/5315137","journal-title":"J Ophthalmol"},{"key":"4133_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF00697017","volume":"30","author":"T Tabira","year":"1974","unstructured":"Tabira T, Goto I, Kuroiwa Y et al (1974) Neuropathological and biochemical studies in Fabry\u2019s disease. Acta Neuropathol 30:345\u2013354. https:\/\/doi.org\/10.1007\/BF00697017","journal-title":"Acta Neuropathol"},{"key":"4133_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.99171","author":"JJ Miller","year":"2018","unstructured":"Miller JJ, Aoki K, Moehring F et al (2018) Neuropathic pain in a Fabry disease rat model. JCI Insight. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.99171","journal-title":"JCI Insight"},{"key":"4133_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.172869","author":"TB Waltz","year":"2024","unstructured":"Waltz TB, Chao D, Prodoehl EK et al (2024) Fabry disease Schwann cells release p11 to induce sensory neuron hyperactivity. JCI Insight. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.172869","journal-title":"JCI Insight"},{"key":"4133_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1212\/WNL.52.6.1249","volume":"52","author":"LJC Scott","year":"1999","unstructured":"Scott LJC, Griffin JW, Luciano C et al (1999) Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52:1249\u20131254. https:\/\/doi.org\/10.1212\/WNL.52.6.1249","journal-title":"Neurology"},{"key":"4133_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-61","author":"AP Burlina","year":"2011","unstructured":"Burlina AP, Sims KB, Politei JM et al (2011) Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol. https:\/\/doi.org\/10.1186\/1471-2377-11-61","journal-title":"BMC Neurol"},{"key":"4133_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5152\/NPA.2015.7646","volume":"52","author":"\u00c7K Akpinar","year":"2015","unstructured":"Akpinar \u00c7K, T\u00fcrker H, Bayrak O et al (2015) Electroneuromyographic features in Fabry disease: a retrospective review. Noro Psikiyatri Ars 52:258\u2013262. https:\/\/doi.org\/10.5152\/NPA.2015.7646","journal-title":"Noro Psikiyatri Ars"},{"key":"4133_CR36","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/S13760-019-01138-Y","volume":"120","author":"R \u0130nan","year":"2020","unstructured":"\u0130nan R, Me\u015fe M, Bicik Z (2020) Multidisciplinary approach to Fabry disease: from the eye of a neurologist. Acta Neurol Belg 120:1333\u20131339. https:\/\/doi.org\/10.1007\/S13760-019-01138-Y","journal-title":"Acta Neurol Belg"},{"key":"4133_CR37","doi-asserted-by":"publisher","unstructured":"Bitirgen G, Turkmen K, Zengin N, et al. (2021) Altered pupillary light responses are associated with the severity of autonomic symptoms in patients with Fabry disease. Scientific Reports 11:8146. https:\/\/doi.org\/10.1038\/s41598-021-87589-x","DOI":"10.1038\/s41598-021-87589-x"},{"key":"4133_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/JMG.20.4.309","volume":"20","author":"N Gadoth","year":"1983","unstructured":"Gadoth N, Sandbank U (1983) Involvement of dorsal root ganglia in Fabry\u2019s disease. J Med Genet 20:309\u2013312. https:\/\/doi.org\/10.1136\/JMG.20.4.309","journal-title":"J Med Genet"},{"key":"4133_CR39","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mus.10497","volume":"28","author":"R Schiffmann","year":"2003","unstructured":"Schiffmann R, Floeter MK, Dambrosia JM et al (2003) Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 28:703\u2013710. https:\/\/doi.org\/10.1002\/mus.10497","journal-title":"Muscle Nerve"},{"key":"4133_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00428-008-0653-2","volume":"453","author":"C Valbuena","year":"2008","unstructured":"Valbuena C, Carvalho E, Bustorff M et al (2008) Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch 453:329\u2013338. https:\/\/doi.org\/10.1007\/s00428-008-0653-2","journal-title":"Virchows Arch"},{"issue":"7","key":"4133_CR41","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10792-022-02626-6","volume":"43","author":"A Mete","year":"2023","unstructured":"Mete A, Dogan L, Ozcakmakci GB et al (2023) Ocular findings and their correlation with disease severity in Fabry disease in south-east Anatolia. Int Ophthalmol 43(7):2301\u20132306. https:\/\/doi.org\/10.1007\/s10792-022-02626-6","journal-title":"Int Ophthalmol"},{"key":"4133_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-023-02932-x","volume":"18","author":"M Lindziute","year":"2023","unstructured":"Lindziute M, Kaufeld J, Hufendiek K et al (2023) Correlation of retinal vascular characteristics with laboratory and ocular findings in Fabry disease: exploring ocular diagnostic biomarkers. Orphanet J Rare Dis 18:1\u201310. https:\/\/doi.org\/10.1186\/s13023-023-02932-x","journal-title":"Orphanet J Rare Dis"},{"key":"4133_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/J.1442-9071.2005.00990.X","volume":"33","author":"TT Nguyen","year":"2005","unstructured":"Nguyen TT, Gin T, Nicholls K et al (2005) Ophthalmological manifestations of Fabry disease: a survey of patients at the royal melbourne fabry disease treatment centre. Clin Exp Ophthalmol 33:164\u2013168. https:\/\/doi.org\/10.1111\/J.1442-9071.2005.00990.X","journal-title":"Clin Exp Ophthalmol"},{"key":"4133_CR44","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.10.14","author":"ME Erdman","year":"2024","unstructured":"Erdman ME, Ch S, Mohiuddin A et al (2024) Fabry disease rat model develops age- and sex-dependent anterior segment ocular abnormalities. Invest Ophthalmol Vis Sci. https:\/\/doi.org\/10.1167\/iovs.65.10.14","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4133_CR45","first-page":"87","volume":"58","author":"G Garmizo","year":"1987","unstructured":"Garmizo G (1987) Ocular manifestations of Fabry\u2019s disease. J Am Optom Assoc 58:87","journal-title":"J Am Optom Assoc"},{"key":"4133_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bjo.2006.100602","volume":"91","author":"A Sodi","year":"2007","unstructured":"Sodi A, Ioannidis AS, Mehta A et al (2007) Ocular manifestations of Fabry\u2019s disease: data from the Fabry outcome survey. Br J Ophthalmol 91:210\u2013214. https:\/\/doi.org\/10.1136\/bjo.2006.100602","journal-title":"Br J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04133-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:19:24Z","timestamp":1781169564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04133-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4133"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04133-4","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was approved by the F\u0131rat University Faculty of Medicine Ethics Committee (Date: 24 April 2025; Decision No: 2025\/7\u201410). The research was executed in compliance with the principles of the Declaration of Helsinki, and informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"261"}}